For 2025, BioPorto is targeting total revenue of DKK 45-60 million, corresponding to a growth in the range of 24-66% compared to 2024. Growth will be driven by increased ProNehro AKI (NGAL) sales, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback